查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1976178

病理检测设备市场：依产品类型、技术、最终用户、应用及通路划分－2026-2032年全球预测

Pathology Instruments Market by Product Type, Technology, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，病理检测设备市场价值将达到 22.9 亿美元，到 2026 年将成长至 24.8 亿美元，到 2032 年将达到 41.4 亿美元，复合年增长率为 8.81%。

主要市场统计数据
基准年 2025 22.9亿美元
预计年份：2026年 24.8亿美元
预测年份 2032 41.4亿美元
复合年增长率 (%) 8.81%

本次演讲清晰而有力地介绍了技术融合和临床需要如何重塑病理设备的采购、工作流程以及与供应商的关係。

病理设备领域正经历着一场由技术融合和不断变化的临床需求所驱动的重大变革。近年来，实验室和检测机构已逐渐从传统的类比工作流程转向以影像数位化、软体分析和自动化检体处理为核心的整合式数位生态系统。为了应对日益增长的诊断处理量和不断提高的准确性要求，这一转变正在重塑采购标准、营运模式和供应商关係。

对重塑病理设备开发、筹资策略、自动化实施和监管准备的关键变革性转变进行了清晰的概述。

病理仪器的格局正受到技术、法规和营运策略等多方面变革的重塑。首先，数位病理和人工智慧成像工作流程的普及正在改变成像系统的价值提案，促使买家在关注光学性能之外，更加重视软体整合、资料管理和检验流程。这种转变加强了仪器供应商、软体供应商和云端平台之间的合作，最终促成端到端解决方案的交付，而非仅仅是独立的硬体。

对美国在 2025 年实施的关税措施如何重塑整个病理设备产业的筹资策略、供应链韧性和生命週期支援计画进行全面分析。

美国将于2025年实施的关税措施和贸易政策变化，迫使整个病理设备生态系统的相关人员重新评估采购、定价和营运策略。关税带来的成本压力可能导致进口零件和整机到岸成本增加，迫使采购团队重新评估供应商选择标准和总体拥有成本（TCO）。为此，製造商和经销商正在探索替代采购途径，增加关键零件的库存，并与全球供应商协商修订后的商业条款，以维持利润率并确保服务水准。

对产品类型、技术、最终用户、应用和分销管道的细分趋势进行权威、详细的分析，为采购和策略规划做出贡献。

细分市场分析揭示了产品、技术、终端用户、应用和分销管道等各个维度上的微妙机会和扩散模式。依产品类型划分，成像系统、切片机、玻片染色系统和组织处理系统特别值得关注。成像系统包括明场成像系统、数位病理系统和萤光成像系统。切片机包括冷冻切片机、旋转切片机和超薄切片机。玻片染色系统分为自动染色系统和手动染色系统。组织处理系统分为浸没式组织处理系统及旋转式组织处理系统。这些差异会影响采购决策；数位病理系统和自动玻片染色系统更适用于高通量和研究密集环境，而专用切片机和萤光成像系统则更适合特定的临床和研究应用。

这种可操作的区域情报突显了主要全球区域在部署、监管环境和基础设施趋势方面的差异如何影响采购和服务策略。

区域趋势差异显着，影响美洲、欧洲、中东和非洲以及亚太地区的战略重点。在美洲，重点在于整合数位化解决方案和服务网络，以支援高通量诊断和研究机构。随着数位化成像技术在各机构的普及，该地区的相关人员越来越重视互通性和资料管治。同时，在欧洲、中东和非洲，不同的法规环境和数位化普及程度，使得对高度适应性解决方案的需求日益增长，这些解决方案既要满足严格的监管要求，又要适应不同的基础设施能力。

对主要企业如何将产品创新、伙伴关係和服务品质结合，以增强竞争优势并加速产品推广应用进行深入分析。

病理设备领域的主要企业正透过研发投入、策略伙伴关係和售后服务相结合的方式，实现产品差异化并增强客户忠诚度。产品蓝图优先考虑软体增强、可根据检查室需求不断演进的模组化平台以及经过检验的工作流程，以简化部署。供应商还透过投资服务基础设施（校准、预防性保养、培训和远距离诊断）来减少停机时间，从而在整个生命週期中展现价值。与数位病理软体公司和云端服务供应商的合作也十分普遍，从而能够提供整合解决方案，将成像硬体、分析功能和安全的资料管理相结合。

为製造商、经销商和医疗保健领导者提供关于优先考虑互通性、供应链弹性和以客户为中心的服务模式以实现永续增长的实用建议。

产业领导者必须采取积极主动的方式，整合技术创新、供应链韧性和以客户为中心的服务模式。首先，应优先考虑成像系统的互通性和检验的整合路径，确保硬体、软体和实验室资讯系统之间的无缝协作。这将减少部署阻力，加快临床检验。同时，应投资于自动化和标准化的样本製备工作流程，以确保结果的可重复性，并减轻高负荷环境下的人工工作负担。这些投资将提高营运效率，并增强对诊断实验室和实验室的价值提案。

透过结合一手访谈、二手分析和专家检验，采用高度透明的多源调查方法，对病理检测设备得出严谨而实用的见解。

本执行摘要的调查方法采用多方面策略，以确保在整合定性和定量分析的同时，进行稳健的检验和三角测量。主要研究包括对实验室经理、采购经理、临床病理学家和研发经理进行结构化访谈，以直接了解他们对工作流程需求、采购标准和服务期望的看法。此外，还对监管指南、产品文件、白皮书和公司资讯披露进行了二次分析，以梳理技术能力、产品系列和服务模式。

展望未来，结论强调了整合创新、韧性和卓越服务的策略必要性，以满足不断变化的临床和研究需求。

病理设备领域正处于变革的关键时期，数位转型、自动化和供应链策略的整合正在重塑临床和科学研究工作流程。相关人员，将更有能力为诊断检查室、医院、製药公司和研究机构创造价值。推动互通性、投资于检验的工作流程以及加强售后服务，将有助于降低采用门槛，并最终改善患者和研究人员的长期效益。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 病理检测设备市场：依产品类型划分

  • 影像系统
    • 明场影像系统
    • 数位病理系统
    • 萤光成像系统
  • 切片机
    • 冷冻切片机
    • 旋转式切片机
    • 超精细切片机
  • 玻片染色装置
    • 自动玻片染色装置
    • 手动玻片染色装置
  • 组织处理设备
    • 潜水式组织治疗装置
    • 旋转式组织处理装置

第九章 病理检测设备市场：依技术划分

  • 自动化
  • 手动的

第十章 病理检测设备市场：依最终用户划分

  • 诊断检查室
  • 医院
  • 製药公司
  • 研究机构

第十一章 病理检测设备市场：依应用领域划分

  • 临床诊断
  • 教育
  • 研究
  • 兽医病理学

第十二章 病理检测设备市场：依通路划分

  • 直销
  • 销售代理
  • 线上管道

第十三章 病理检测设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 病理检测设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 病理检测设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国病理检测设备市场

第十七章：中国病理检测设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio SB
  • Bio-Genex Laboratories
  • Bio-Rad Laboratories, Inc.
  • BrandTech Scientific, Inc.
  • Danaher Corporation
  • Diapath SpA
  • F. Hoffmann-La Roche AG
  • Fujifilm Holdings Corporation
  • GPC Medical Ltd.
  • Hamamatsu Photonics KK
  • Hologic, Inc.
  • Leica Biosystems Nussloch GmbH
  • Liberty Industries, Inc.
  • Merck KGaA
  • Mikroscan Technologies, Inc.
  • PerkinElmer Inc.
  • PHC Holdings Corporation
  • QIAGEN GmbH
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8E22B619330D

The Pathology Instruments Market was valued at USD 2.29 billion in 2025 and is projected to grow to USD 2.48 billion in 2026, with a CAGR of 8.81%, reaching USD 4.14 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.29 billion
Estimated Year [2026] USD 2.48 billion
Forecast Year [2032] USD 4.14 billion
CAGR (%) 8.81%

A clear and compelling introduction outlining how technological convergence and clinical imperatives are reshaping pathology instrument procurement, workflows, and supplier relationships

The pathology instruments landscape is undergoing a profound transformation driven by technological convergence and evolving clinical imperatives. Over recent years laboratories and research institutions have progressively shifted from traditional analogue workflows toward integrated digital ecosystems that emphasize image digitization, software-enabled interpretation, and automated sample handling. This transition is reshaping procurement criteria, operational models, and supplier relationships as diagnostic throughput demands increase and accuracy expectations rise.

In parallel, healthcare providers and life science organizations are placing greater emphasis on interoperability, regulatory compliance, and lifecycle support. As a result, instrument manufacturers and distributors are adapting by enhancing service offerings, expanding training programs, and developing partnerships with software and services firms. These changes are not isolated; they represent a broader reorientation of pathology practice toward efficiency, reproducibility, and data-driven diagnostics. Moving forward, stakeholders should anticipate continued emphasis on integration of imaging, sample preparation, and analytics to meet clinical and research objectives while maintaining quality and patient safety.

An incisive overview of the major transformative shifts reshaping pathology instrument development, procurement strategies, automation adoption, and regulatory preparedness

The landscape for pathology instruments is being reshaped by several transformative shifts that span technology, regulation, and operational strategy. First, the proliferation of digital pathology and AI-enabled imaging workflows is altering the value proposition of imaging systems, prompting buyers to prioritize software integration, data management, and validation pathways alongside optical performance. This shift increases collaboration between instrument vendors, software providers, and cloud platforms to deliver end-to-end solutions rather than standalone hardware.

Second, automation across sample preparation-encompassing microtomes, slide stainers, and tissue processors-is accelerating to reduce manual handling, improve consistency, and increase throughput in high-volume diagnostic settings. The drive toward laboratory automation is reinforced by workforce pressures and the imperative to reduce turnaround times. Third, supply chain resilience and localization strategies are gaining prominence; procurement teams are evaluating vendor risk, parts availability, and service footprint more rigorously to mitigate disruption. Finally, regulatory scrutiny and quality standards continue to evolve, requiring manufacturers to invest in validation, documentation, and post-market surveillance. Taken together, these shifts are creating a competitive environment where integration, service excellence, and regulatory readiness are as important as hardware innovation.

A comprehensive analysis of how United States tariff measures in 2025 are reshaping sourcing strategies, supply chain resilience, and lifecycle support planning across the pathology instruments landscape

The introduction of tariff measures and trade policy changes in the United States during 2025 has reinforced the need for stakeholders across the pathology instruments ecosystem to reassess sourcing, pricing, and operational strategies. Tariff-driven cost pressures have the potential to increase landed costs for imported components and finished systems, prompting procurement teams to re-evaluate supplier selection criteria and total cost of ownership considerations. In response, manufacturers and distributors are exploring alternative sourcing lanes, increasing inventories of critical components, and negotiating revised commercial terms with global suppliers to preserve margin and maintain service levels.

In addition to procurement impacts, tariff dynamics influence strategic decisions about manufacturing footprints and after-sales support. Some companies are accelerating efforts to diversify production sites or to strengthen local assembly and calibration capabilities to reduce exposure to trade frictions and logistical bottlenecks. Service networks and spare-parts planning are being adapted to shorten lead times and reduce dependency on cross-border shipments. Importantly, regulatory and contract compliance processes are also affected, as changes in tariff regimes necessitate updated customs classifications and documentation protocols. Overall, the cumulative effect of tariff shifts is prompting a more resilient and flexible approach to supply chain design, supplier partnerships, and lifecycle support arrangements across the pathology instruments landscape.

An authoritative and nuanced breakdown of segmentation dynamics across product types, technology, end users, applications, and distribution channels to inform procurement and strategy

Segmentation insights reveal nuanced opportunities and adoption patterns across product, technology, end user, application, and distribution dimensions. Based on product type, attention centers on imaging systems, microtomes, slide stainers, and tissue processors, where imaging systems encompass brightfield imaging systems, digital pathology systems, and fluorescence imaging systems; microtomes include cryostat microtomes, rotary microtomes, and ultramicrotomes; slide stainers are delineated into automated slide stainers and manual slide stainers; and tissue processors are differentiated into immersion tissue processors and rotor tissue processors. These distinctions drive procurement decisions, with digital pathology systems and automated slide stainers often prioritized for high-throughput or research-intensive settings while specialized microtomes and fluorescence imaging are chosen for niche clinical and research applications.

Considering technology, systems are categorized into automated and manual variants, with automation gaining traction in diagnostic laboratories seeking consistency and efficiency, while manual platforms continue to retain relevance in low-volume or specialized workflows. For end users, diagnostic laboratories and hospitals typically prioritize throughput, regulatory compliance, and integration with laboratory information systems, whereas pharmaceutical companies and research institutes emphasize flexibility, advanced imaging capabilities, and customization for research protocols. In terms of application, clinical diagnostics, education, research, and veterinary pathology each present distinct requirements that influence specification and service expectations. Finally, distribution channel segmentation-direct sales, distributors, and online channels-affects lead times, customization options, and after-sales support, with direct sales facilitating tailored deployments and distributor or online channels enabling broader reach and faster procurement cycles.

Actionable regional intelligence highlighting how varying adoption, regulatory landscapes, and infrastructure dynamics influence procurement and service strategies across key global regions

Regional dynamics differ significantly and inform strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, emphasis is placed on integrated digital solutions and consolidating service networks to support high-volume diagnostic facilities and research centers. Stakeholders in this region are increasingly focusing on interoperability and data governance considerations as institutions adopt laboratory-wide digital imaging initiatives. By contrast, Europe, Middle East & Africa presents a mosaic of regulatory environments and varying levels of digital adoption, driving demand for adaptable solutions that meet stringent regulatory requirements while accommodating diverse infrastructure capabilities.

Asia-Pacific is characterized by rapid investment in diagnostic infrastructure, growing adoption of automation, and an expanding base of domestic manufacturers. Procurement strategies in this region often balance cost considerations with a drive for advanced functionality, leading to hybrid approaches that combine local sourcing with imported high-specification imaging and analytics tools. Across regions, service coverage, training availability, and supply chain agility remain critical determinants of vendor selection. Consequently, manufacturers and distributors tailoring regional strategies must align product portfolios, regulatory pathways, and go-to-market models with localized clinical workflows and procurement norms to maximize uptake and long-term value.

Insightful analysis of how leading firms are combining product innovation, partnerships, and service excellence to strengthen competitive positioning and accelerate adoption

Leading companies in the pathology instruments space are deploying a mix of R&D investment, strategic partnerships, and aftermarket services to differentiate their offerings and strengthen customer loyalty. Product roadmaps increasingly prioritize software-enabled functionality, modular platforms that can evolve with laboratory needs, and validated workflows to accelerate adoption. Vendors are also investing in service infrastructure-calibration, preventive maintenance, training, and remote diagnostics-to reduce downtime and demonstrate total lifecycle value. Partnerships with digital pathology software firms and cloud providers are common, enabling integrated solutions that combine imaging hardware with analytics and secure data management.

Corporate strategies include targeted collaborations with research institutions and diagnostic networks to co-develop applications and validate performance in real-world settings. Some firms focus on expanding geographic reach through channel partnerships and localized service hubs, while others pursue selective acquisition to fill capability gaps or gain access to specialized technologies. Competitive differentiation increasingly hinges on the ability to offer end-to-end solutions that reduce the barriers to digital adoption, provide clear regulatory documentation, and deliver measurable improvements in throughput and diagnostic consistency. As the industry evolves, companies that balance product innovation with robust service ecosystems and strategic commercial models will be best positioned to capture long-term opportunities.

Actionable recommendations for manufacturers, distributors, and healthcare leaders to prioritize interoperability, supply chain resilience, and customer-centric service models for sustainable growth

Industry leaders should adopt a proactive posture that integrates technological innovation, supply chain resilience, and customer-centric service models. First, prioritize interoperability and validated integration pathways for imaging systems so that hardware, software, and laboratory information systems operate seamlessly, reducing friction during deployments and accelerating clinical validation. In parallel, invest in automation and standardized sample preparation workflows to deliver reproducible results and lower the burden of manual processes in high-volume settings. These investments will improve operational efficiency and enhance the value proposition presented to diagnostic laboratories and research organizations.

Second, diversify supply chains and consider localized assembly or regional distribution hubs to mitigate tariff exposure and shipping disruptions. Strengthening after-sales support through remote diagnostics, preventive maintenance programs, and targeted training will reduce downtime risks and increase customer retention. Third, develop flexible commercial models that include service contracts, modular upgrades, and outcome-oriented agreements to align vendor and customer incentives. Finally, deepen engagement with regulatory and clinical stakeholders to streamline validation pathways and to demonstrate clinical utility and compliance. By pursuing these priorities, organizations can improve resilience, accelerate adoption of advanced solutions, and deliver measurable operational and clinical benefits to end users.

A transparent, multi-source research methodology combining primary interviews, secondary analysis, and expert validation to produce rigorous and actionable pathology instruments insights

The research methodology underpinning this executive summary combined a multi-source approach to synthesize qualitative and quantitative insights while ensuring robust validation and triangulation. Primary research included structured interviews with laboratory directors, procurement leaders, clinical pathologists, and R&D managers to capture firsthand perspectives on workflow requirements, purchasing criteria, and service expectations. These insights were complemented by secondary analysis of regulatory guidance, product literature, white papers, and company disclosures to map technology capabilities, product portfolios, and service models.

To enhance reliability, findings were validated through expert review panels composed of industry practitioners and academic specialists who assessed the relevance and applicability of conclusions across clinical and research settings. Segmentation frameworks were developed iteratively, aligning product, technology, end user, application, and distribution dimensions with operational realities observed in the field. Throughout the process, data triangulation methods were applied to reconcile divergent inputs and to ensure consistency. The methodology emphasizes transparency in source types and validation steps to provide stakeholders with confidence in the strategic implications and recommendations presented.

A forward-looking conclusion emphasizing the strategic imperative to integrate innovation, resilience, and service excellence to meet evolving clinical and research demands

The pathology instruments landscape is at an inflection point where digital transformation, automation, and supply chain strategy converge to redefine clinical and research workflows. Stakeholders who align product development, commercialization, and service models with these forces will be better positioned to deliver value across diagnostic laboratories, hospitals, pharmaceutical companies, and research institutes. Embracing interoperability, investing in validated workflows, and strengthening after-sales capabilities will reduce barriers to adoption and improve long-term outcomes for patients and researchers alike.

Looking ahead, success will be determined by the ability to integrate imaging, sample preparation, and analytics into coherent solutions that address real-world operational challenges. Organizations that proactively adapt to tariff dynamics, regional differentiation, and evolving regulatory expectations will sustain competitive advantage. In summary, the path forward favors those who combine technological innovation with resilient commercial and service strategies to meet the complex needs of modern pathology practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pathology Instruments Market, by Product Type

  • 8.1. Imaging Systems
    • 8.1.1. Brightfield Imaging Systems
    • 8.1.2. Digital Pathology Systems
    • 8.1.3. Fluorescence Imaging Systems
  • 8.2. Microtomes
    • 8.2.1. Cryostat Microtomes
    • 8.2.2. Rotary Microtomes
    • 8.2.3. Ultramicrotomes
  • 8.3. Slide Stainers
    • 8.3.1. Automated Slide Stainers
    • 8.3.2. Manual Slide Stainers
  • 8.4. Tissue Processors
    • 8.4.1. Immersion Tissue Processors
    • 8.4.2. Rotor Tissue Processors

9. Pathology Instruments Market, by Technology

  • 9.1. Automated
  • 9.2. Manual

10. Pathology Instruments Market, by End User

  • 10.1. Diagnostic Laboratories
  • 10.2. Hospitals
  • 10.3. Pharmaceutical Companies
  • 10.4. Research Institutes

11. Pathology Instruments Market, by Application

  • 11.1. Clinical Diagnostics
  • 11.2. Education
  • 11.3. Research
  • 11.4. Veterinary Pathology

12. Pathology Instruments Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Channels

13. Pathology Instruments Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pathology Instruments Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pathology Instruments Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pathology Instruments Market

17. China Pathology Instruments Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Agilent Technologies, Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Bio SB
  • 18.9. Bio-Genex Laboratories
  • 18.10. Bio-Rad Laboratories, Inc.
  • 18.11. BrandTech Scientific, Inc.
  • 18.12. Danaher Corporation
  • 18.13. Diapath S.p.A.
  • 18.14. F. Hoffmann-La Roche AG
  • 18.15. Fujifilm Holdings Corporation
  • 18.16. GPC Medical Ltd.
  • 18.17. Hamamatsu Photonics K.K.
  • 18.18. Hologic, Inc.
  • 18.19. Leica Biosystems Nussloch GmbH
  • 18.20. Liberty Industries, Inc.
  • 18.21. Merck KGaA
  • 18.22. Mikroscan Technologies, Inc.
  • 18.23. PerkinElmer Inc.
  • 18.24. PHC Holdings Corporation
  • 18.25. QIAGEN GmbH
  • 18.26. Siemens Healthineers AG
  • 18.27. Sysmex Corporation
  • 18.28. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATHOLOGY INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PATHOLOGY INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY BRIGHTFIELD IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY BRIGHTFIELD IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY BRIGHTFIELD IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIGITAL PATHOLOGY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIGITAL PATHOLOGY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIGITAL PATHOLOGY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CRYOSTAT MICROTOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CRYOSTAT MICROTOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CRYOSTAT MICROTOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ROTARY MICROTOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ROTARY MICROTOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ROTARY MICROTOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ULTRAMICROTOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ULTRAMICROTOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ULTRAMICROTOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY AUTOMATED SLIDE STAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY AUTOMATED SLIDE STAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY AUTOMATED SLIDE STAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MANUAL SLIDE STAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MANUAL SLIDE STAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MANUAL SLIDE STAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMMERSION TISSUE PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMMERSION TISSUE PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMMERSION TISSUE PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ROTOR TISSUE PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ROTOR TISSUE PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ROTOR TISSUE PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY VETERINARY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY VETERINARY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY VETERINARY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 218. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 219. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 220. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. G7 PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 228. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 230. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. NATO PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL PATHOLOGY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY MICROTOMES, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY SLIDE STAINERS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TISSUE PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA PATHOLOGY INSTRUMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)